首页> 美国卫生研究院文献>BMC Medical Genomics >Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders
【2h】

Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders

机译:异基因造血细胞移植治疗血液系统疾病的儿童中aGvHD的早期肠道菌群特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe onset of acute Graft-versus-Host Disease (aGvHD) has been correlated with the gut microbiota (GM) composition, but experimental observations are still few, mainly involving cohorts of adult patients. In the current scenario where fecal microbiota transplantation has been used as a pioneer therapeutic approach to treat steroid-refractory aGvHD, there is an urgent need to expand existing observational studies of the GM dynamics in Hematopoietic Stem Cell Transplantation (HSCT). Aim of the present study is to explore the GM trajectory in 36 pediatric HSCT recipients in relation to aGvHD onset.
机译:背景:急性移植物抗宿主病(aGvHD)的发病与肠道菌群(GM)的组成有关,但实验观察仍然很少,主要涉及成年患者。在目前的情况下,粪便菌群移植已被用作治疗类固醇难治性aGvHD的先锋疗法,迫切需要扩大现有的关于造血干细胞移植(HSCT)中GM动态的观察性研究。本研究的目的是探讨与aGvHD发病有关的36例小儿HSCT接受者的GM轨迹。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号